<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04219410</url>
  </required_header>
  <id_info>
    <org_study_id>1279152-4</org_study_id>
    <nct_id>NCT04219410</nct_id>
  </id_info>
  <brief_title>Assessment of a Modified Minimally Invasive Esophagectomy</brief_title>
  <official_title>Assessment of a Modified Minimally Invasive Esophagectomy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Kaiser Permanente</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Kaiser Permanente</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a retrospective case series of a novel fully minimally invasive esophagectomy
      procedure for patients with primary esophageal cancer.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">January 1, 2013</start_date>
  <completion_date type="Actual">August 31, 2016</completion_date>
  <primary_completion_date type="Actual">August 31, 2016</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Hospital length of stay</measure>
    <time_frame>Through study completion, an average of 2.9 years</time_frame>
    <description>Hospital length of stay</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Intensive care unit length of stay</measure>
    <time_frame>Through study completion, an average of 2.9 years</time_frame>
    <description>Intensive care unit length of stay</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Feeding tube placement</measure>
    <time_frame>Intra-operatively</time_frame>
    <description>Feeding tube placement</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of patients with inpatient mortality</measure>
    <time_frame>Through study completion, an average of 2.9 years</time_frame>
    <description>Number of patients with inpatient mortality</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>90-day total mortality</measure>
    <time_frame>90 days post discharge</time_frame>
    <description>90-day total mortality</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of patients with hospital readmission within 30 days</measure>
    <time_frame>30 days post discharge</time_frame>
    <description>Number of patients with hospital readmission within 30 days</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of patients with complications</measure>
    <time_frame>Hospital stay and 30 days post discharge</time_frame>
    <description>Number of patients with medical and surgical complications both inpatient and post-discharge</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">142</enrollment>
  <condition>Esophageal Cancer</condition>
  <arm_group>
    <arm_group_label>Cases</arm_group_label>
    <description>Patients who underwent minimally invasive esophagectomy with this novel procedure at Kaiser Permanente, Northern California, Oakland Medical Center</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Fully minimally invasive esophagectomy</intervention_name>
    <description>Esophagectomy using a novel fully minimally invasive approach</description>
    <arm_group_label>Cases</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Consecutive sample of all patients undergoing the novel minimally invasive esophagectomy
        procedure at the Kaiser Permanente Northern California Oakland Medical Center during the
        study period
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  patient with primary esophageal cancer of any cell type

          -  underwent the novel minimally invasive esophagectomy procedure at the Kaiser
             Permanente Northern California Oakland Medical Center by one of the study
             author-surgeons

        Exclusion Criteria:

          -  non-elective procedure

          -  less than 90 days of post-discharge follow-up
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>99 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Andrew Avins, MD, MPH</last_name>
    <role>Principal Investigator</role>
    <affiliation>Kaiser Permanente</affiliation>
  </overall_official>
  <verification_date>January 2020</verification_date>
  <study_first_submitted>January 3, 2020</study_first_submitted>
  <study_first_submitted_qc>January 3, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">January 7, 2020</study_first_posted>
  <last_update_submitted>January 3, 2020</last_update_submitted>
  <last_update_submitted_qc>January 3, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">January 7, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Kaiser Permanente</investigator_affiliation>
    <investigator_full_name>Andy Avins</investigator_full_name>
    <investigator_title>Senior Research Scientist</investigator_title>
  </responsible_party>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

